StreetInsider.com News Articles

Form DEF 14A Co-Diagnostics, Inc. For: Oct 26

Mon, 26 Oct 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20261026/27233886.html

CoMira Diagnostics invited to Saudi manufacturing forum in November

Tue, 20 Oct 2026 09:15:17 -0400

Co-Diagnostics, Inc. (Nasdaq: CODX) announced that CoMira Diagnostics, its joint venture with Arabian Eagle Manufacturing in the Kingdom of Saudi Arabia, has been invited by Saudi Arabia's Ministry of Industry and Mineral Resources to participate in the NUWATIN 2026 Forum, scheduled for November 2026.

The forum will be held under the patronage of Prince Abdulaziz bin Salman Al Saud, Minister of Industry and Mineral Resources, and is expected to bring together senior government officials and industry leaders to discuss strategic industrial investments, technology transfer, and manufacturing localization projects.

The invitation follows the execution of a lease for a planned manufacturing facility in

Co-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum

Tue, 20 Oct 2026 09:15:00 -0400

Participation in NUWATIN 2026 to Support Advancement of Strategic Manufacturing, Technology Transfer, and Industrial Localization Initiatives Under Saudi Vision 2030

Invitation Follows Execution of Manufacturing Facility Lease in Sudair Industrial City

SALT LAKE CITY, Oct. 20, 2026 /PRNewswire/ -- Co-Diagnostics,

Co-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum

Tue, 20 Oct 2026 09:15:00 -0400

Participation in NUWATIN 2026 to Support Advancement of Strategic Manufacturing, Technology Transfer, and Industrial Localization Initiatives Under Saudi Vision 2030

Invitation Follows Execution of Manufacturing Facility Lease in Sudair Industrial City

SALT LAKE CITY, Oct. 20, 2026 /PRNewswire/ -- Co-Diagnostics,

Form PRE 14A Co-Diagnostics, Inc. For: Oct 16

Mon, 19 Oct 2026 12:28:00 -0400

si-local-file:///var/storage/secattach/20261019/27202889.html

Form 8-K Co-Diagnostics, Inc. For: Oct 14

Thu, 15 Oct 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20261015/27193582.html

Co-Diagnostics Highlights PCR Platform Capabilities for Potential Plague Detection

Thu, 15 Oct 2026 09:15:00 -0400

Existing Sputum Sample-Preparation Technology Provides Potential Foundation for Plague Diagnostics

Draws on Rapid-Response Experience with COVID-19, Mpox and Ebola Supported by Expanded Manufacturing Infrastructure

SALT LAKE CITY, Oct. 15, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics

Co-Diagnostics Highlights PCR Platform Capabilities for Potential Plague Detection

Thu, 15 Oct 2026 09:15:00 -0400

Existing Sputum Sample-Preparation Technology Provides Potential Foundation for Plague Diagnostics

Draws on Rapid-Response Experience with COVID-19, Mpox and Ebola Supported by Expanded Manufacturing Infrastructure

SALT LAKE CITY, Oct. 15, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics

Form 8-K/A Co-Diagnostics, Inc. For: Oct 09

Thu, 15 Oct 2026 06:10:00 -0400

si-local-file:///var/storage/secattach/20261015/27189164.html

Form 8-K Co-Diagnostics, Inc. For: Oct 09

Tue, 13 Oct 2026 06:10:00 -0400

si-local-file:///var/storage/secattach/20261013/27176408.html

Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe

Thu, 08 Oct 2026 09:26:00 -0400

Ute Indian Tribe Mosquito Abatement Department to bring PCR-based mosquito surveillance testing in house

SALT LAKE CITY, Oct. 8, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has received an order from the Ute Indian Tribe Mosquito

Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe

Thu, 08 Oct 2026 09:26:00 -0400

Ute Indian Tribe Mosquito Abatement Department to bring PCR-based mosquito surveillance testing in house

Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease

Wed, 07 Oct 2026 09:00:00 -0400

New Executive Order prioritizes improved detection and calls for federal R&D programs for rapid diagnostics for mosquito- and tick-borne diseases

Company to participate in October 9 Utah Global Health Leadership roundtable and four regional mosquito control conferences this fall

SALT LAKE CITY, Oct. 7, 2026 /PRNewswire/

Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease

Wed, 07 Oct 2026 09:00:00 -0400

New Executive Order prioritizes improved detection and calls for federal R&D programs for rapid diagnostics for mosquito- and tick-borne diseases

Company to participate in October 9 Utah Global Health Leadership roundtable and four regional mosquito control conferences this fall

SALT LAKE CITY, Oct. 7, 2026 /PRNewswire/

Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development

Tue, 06 Oct 2026 09:00:00 -0400

Ebola Assay in Development for Decentralized Testing on the Co-Dx PCR Platform

SALT LAKE CITY, Oct. 6, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced its upcoming participation at WHX Labs Johannesburg, taking place October 6-8, 2026, at the Gallagher

Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development

Tue, 06 Oct 2026 09:00:00 -0400

Ebola Assay in Development for Decentralized Testing on the Co-Dx PCR Platform

Form 8-K Co-Diagnostics, Inc. For: Sep 30

Mon, 05 Oct 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20261005/27145060.html

Form 8-K Co-Diagnostics, Inc. For: Sep 03

Fri, 25 Sep 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20260925/27107985.html

Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week

Wed, 23 Sep 2026 09:00:00 -0400

Events Bring Together Global Health Leaders to Examine Tuberculosis and Preparedness for the Next Respiratory Pandemic

SALT LAKE CITY, Sept. 23, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that Seth Egan, Chief Commercialization Officer, will represent the Company at

Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week

Wed, 23 Sep 2026 09:00:00 -0400

Events Bring Together Global Health Leaders to Examine Tuberculosis and Preparedness for the Next Respiratory Pandemic

Form PRE 14A Co-Diagnostics, Inc. For: Sep 21

Mon, 21 Sep 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260921/27085967.html

Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation

Mon, 21 Sep 2026 09:00:00 -0400

Roundtable discussion, taking place in New York City, will examine the ongoing Ebola outbreak and technologies needed to strengthen future outbreak response.

Co-Dx will join officials from the U.S. Department of State's Bureau of Global Health Security and Diplomacy and leaders from across the global health research and development community.

Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation

Mon, 21 Sep 2026 09:00:00 -0400

Roundtable discussion, taking place in New York City, will examine the ongoing Ebola outbreak and technologies needed to strengthen future outbreak response.

Co-Dx will join officials from the U.S. Department of State's Bureau of Global Health Security and Diplomacy and leaders from across the global health research and development community.

Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026

Thu, 17 Sep 2026 09:00:00 -0400

SALT LAKE CITY, Sept. 17, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it will participate in the upcoming joint WHO/Unitaid/UNAIDS Annual Consultation Meeting. Joseph Featherstone, Executive Vice President of Business Development, will represent Co-Dx at the annual meeting, which will be held at the

Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026

Thu, 17 Sep 2026 09:00:00 -0400